ICT&health November 10, 2025
Artificial intelligence (AI) is rapidly transforming biomedical research. A new study from Vanderbilt University Medical Center shows just how powerful it can be. By combining AI with advanced “protein language models,” researchers have developed a method to accelerate the design of monoclonal antibodies that can prevent or reduce the severity of life-threatening viral infections.
The research, carried out in collaboration with institutions in the U.S., Australia and Sweden, demonstrates that AI can design functional human antibodies that recognize specific viral surface proteins, without needing an existing antibody as a starting point. This could mark a major step toward a future where biologic drugs are designed entirely by computers. The study was recently published in Cell.
Important milestone
“Our study represents...
Today's Sponsors
Today's Sponsor